Panacea Biotec Ltd (PANACEABIO) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Panacea Biotec Ltd reported sales of ₹199.57 Cr, operating profit of ₹5.67 Cr (OPM 2.84%) and net profit of ₹2.2 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
PANACEABIO quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 147.35 163.49 132.53 166.7 141.13 165.19 166.75 199.57 Expenses 140.35 155.53 159.41 167.88 158.92 153.45 164.18 193.9 Operating Profit 7 7.96 -26.88 -1.18 -17.79 11.74 2.57 5.67 OPM 4.75% 4.87% -20.28% -0.71% -12.61% 7.11% 1.54% 2.84% Other Income 7.42 6.39 36.3 16.99 9.1 5.05 5.26 6.98 Interest 0.98 0.99 1.04 0.86 2.14 1.85 1.2 1.18 Depreciation 8.68 8.98 8.42 8.39 8.34 8.45 7.88 7.9 Profit before tax 4.76 4.38 -0.04 6.56 -19.17 6.49 -1.25 3.57 Tax 1.05% -1.37% 4,875% 39.63% -26.92% 40.06% -20% 38.38% Net Profit 4.71 4.44 -1.99 3.96 -14.01 3.89 -1 2.2 EPS in Rs 0.78 0.74 -0.31 0.66 -2.27 0.65 0.08 0.38
PANACEABIO profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 661 460 559 559 640 673 Expenses 674 558 579 584 644 670 Operating Profit -13 -98 -20 -25 -5 2 OPM -2% -21% -3.5% -4.4% -0.7% 0.3% Other Income 1,687 154 62 55 36 26 Interest 181 4 4 4 6 6 Depreciation 44 39 37 35 33 33 Profit before tax 1,449 13 1 -8 -7 -10 Tax 26% 363% 201% 10% -3% - Net Profit 1,078 -34 -2 -9 -7 -9 EPS in Rs 175.91 -5.42 -0.19 -1.37 -0.88 -1.16 Dividend Payout 0% 0% 0% 0% 0% -
PANACEABIO balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 6 6 6 6 6 Reserves 837 836 829 820 829 Borrowings 20 21 22 23 24 Other Liabilities 407 378 433 405 404 Total Liabilities 1,271 1,241 1,290 1,254 1,262 Fixed Assets 600 582 567 594 620 CWIP 42 102 128 110 100 Investments 13 40 3 3 10 Other Assets 615 517 592 547 532 Total Assets 1,271 1,241 1,290 1,254 1,262
PANACEABIO cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity -108 -422 0 -27 17 Cash from Investing Activity 1,283 430 10 65 -40 Cash from Financing Activity -1,176 -18 -3 -3 -1 Net Cash Flow -2 -10 7 35 -25 Free Cash Flow -119 -424 -71 -77 -37 CFO/OP -2,235% 429% -12% 108% -496%
PANACEABIO ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 45 48 37 47 42 Inventory Days 296 292 282 391 251 Days Payable 327 256 244 413 247 Cash Conversion Cycle 14 83 76 25 46 Working Capital Days -229 -5 -2 44 57 ROCE -6% -10% -4% -5% -2%